Abstract:Objectives To observe the change of high-sensitivity C-reactive protein (hs-CRP) level during therapy with percutaneous coronary intervention (PCI) or medicines in patients with acute myocardial infarction (AMI), and to compare the relation between hs-CRP and the main adverse cardiovascular events (MACE) in-hospital. Methods The 52 patients with AMI were divided into PCI group or medical group. Venous blood samples were taken to examine plasma hs-CRP level at instanter 6 hs, 12 hs, 18 hs, 24 hs, 48 hs, 72 hs, 7 days after admission, To observe the change of hs-CRP and compare the relation between hs-CRP and the MACE in-hospital. Results The MACE incidence rate of medical group was significantly higher than that of PCI group (P0.01). There were no significantly differences between the instant and peak hs-CRP density (P0.05) between two groups, in-hospital instant hs-CRP hs-CRP level correlated significantly to the MACE of medical group (r=0.728,P=0.026), but in PCI group, the relativity is not significance. (r=0.294, P=0.091). In the medical group, the MACE occurrence rate of the patient of the instant hs-CRP level 3 mg/L shows significantly higher than that of the hs-CRP instant level 3 mg/L (P0.05), but in the PCI group, which has no significant difference (P0.05). The peak density of hs-CRP has no related significantly to the MACE in-hospital between two groups (P0.05); on the basis of the hs-CRP peak level 12 mg/L and 12 mg/L divide two pieces to compre, the incidence rate of MACE has no significant difference between two groups (P0.05). Conclusions The MACE rate of PCI treatment is significantly lower than that of medicine therapy in patients with AMI. The in-hospital instant hs-CRP density is significantly related to the incidence of MACE, patients of the instant hs-CRP densith 3 mg/L should best choose PCI to reduce the incidence of MACE in-hospital. The hs-CRP peak density isn't significantly related to the incidence of MACE, it shouldn't to be a marker that coach to keep away the MACE in-hospital.

Homocysteine and hypersensitivity C-reactive protein in patients with acute myocardial infarction

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

The Relationship of Homocysteine Levels to Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Acute Coronary Syndrome Patients

Relationship Between the High-Sensitivity C-reactive Protein,cardiac Troponin I and Severity of Coronary Lesion

Application of Homocysteine and High Sensitive C-reactive Protein in Acute Cerebral Infarction

Application Value of Serum Hcy and hs-CRP Levels in Early Diagnosis of AMI

Clinical study of correlation between plasma homocysteine (Hcy)、hypersensitive C-reactive protein(hs-CRP) and coronary heart disease(CHD)

Value of hypersensitive C-reactive protein for predicting the prognosis of patients after emergent percutaneous coronary intervention

Clinical significance of serum homocysteine and high-sensitivity C-reactive protein in patients with progressive cerebral infarction

Myocardia Infarction Patients with Serum Homocysteine,and High Sensitive C-reactive Protein,lipid and Apolipoprotein E and Related Test Results of the Evaluation Study

Relationship between plasma homocysteine and clinical prognosis in patients of acute myocardial infarction

Homocysteine and risk factors in patients with atherosclerotic myocardial infarction and cerebral infarction:a comparative analysis

Clinical Significance of Detecting Serum Levels of Hcy,hs-CRP,Cys-C in Patients with Acute Myocardial Infarction

The Prognostic Value of Serum Homocysteine Level in Patients with Acute Myocardial Infarction after Primary Percutaneous Coronary Intervention

The Change and Signficance of High-Sensitivity C-reactive Protein Level in Different Therapies for Patients with Acute Myocardial Infarction

Increased Complements and High-Sensitivity C-Reactive Protein Predict Heart Failure in Acute Myocardial Infarction

Impact Of Hyperhomocysteinemia On Coronary Microcirculation In Patients Referred For Elective Coronary Angiography

Detection of Inflammatory Factors in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention and their Relationships with Prognosis

High-sensitivity C-reactive Protein Levels and its Clinical Signiifcance in Patients with Acute Cerebral Infarction

The Role of Serum High Sensitive C-reactive Protein and Matrix Metalloproteinase-9 in Risk Stratification of Patients with Acute Coronary Syndrome

Clinical Significance of Plasma High Sensitive C-reactive Protein and Matrix Metalloproteinase-9 in Acute Myocardial Infarction